COR vs STEK
Cencora, Inc. and Stemtech Corporation, side by side — 6 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | COR | STEK |
|---|---|---|
| Revenue | $321.3B | $2.9M |
| Net income | $1.6B | $-4.0M |
| Gross margin | 3.6% | 80.3% |
| Net margin | 0.5% | −140.7% |
| Return on equity | 144.3% | — |
| Diluted EPS | $7.96 | −$0.02 |
| Dividend / share | $2.20 | — |
| Payout ratio | 28.1% | — |
| Free cash flow | $3.2B | $-483,583 |
| Equity | $1.5B | $-7.0M |
| Net debt / equity | 2.19× | — |
| Current ratio | 0.90× | 0.04× |
| Revenue CAGR 5y | 11.1% | −8.1% |
| Profit CAGR 5y | — | — |
COR bills 111714.3× the revenue of STEK, and STEK closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
6 years side by side
| Fiscal year | COR | STEK |
|---|---|---|
| FY2025 | $321.3B | $2.9M |
| FY2024 | $294.0B | $5.1M |
| FY2023 | $262.2B | $4.9M |
| FY2022 | $238.6B | $4.6M |
| FY2021 | $214.0B | $4.3M |
| FY2020 | $189.9B | $4.4M |
Net income by year
Bottom line
| Fiscal year | COR | STEK |
|---|---|---|
| FY2025 | $1.6B | $-4.0M |
| FY2024 | $1.5B | $-3.8M |
| FY2023 | $1.7B | $-5.4M |
| FY2022 | $1.7B | $-8.5M |
| FY2021 | $1.5B | $-7.1M |
| FY2020 | $-3.4B | $-916,697 |
Advertisement
AdSense · Rectangle 336×280